Twin City Private Wealth LLC Buys 72 Shares of UnitedHealth Group Incorporated $UNH

Twin City Private Wealth LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 6.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,274 shares of the healthcare conglomerate’s stock after acquiring an additional 72 shares during the period. Twin City Private Wealth LLC’s holdings in UnitedHealth Group were worth $398,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Atlantic Edge Private Wealth Management LLC boosted its holdings in UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after acquiring an additional 25 shares during the last quarter. HHM Wealth Advisors LLC boosted its holdings in UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after acquiring an additional 26 shares during the last quarter. Brogan Financial Inc. boosted its holdings in shares of UnitedHealth Group by 3.4% during the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock worth $429,000 after buying an additional 27 shares in the last quarter. West Wealth Group LLC boosted its holdings in shares of UnitedHealth Group by 3.2% during the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock worth $462,000 after buying an additional 27 shares in the last quarter. Finally, Hemington Wealth Management boosted its holdings in shares of UnitedHealth Group by 2.5% during the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock worth $604,000 after buying an additional 28 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on UNH. Royal Bank Of Canada increased their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a report on Wednesday. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the stock an “outperform” rating in a report on Wednesday. Oppenheimer lowered their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Morgan Stanley upped their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Finally, Truist Financial upped their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Trading Down 1.0%

NYSE UNH opened at $341.46 on Friday. The firm has a market capitalization of $309.25 billion, a P/E ratio of 17.82, a PEG ratio of 2.28 and a beta of 0.47. The business has a fifty day simple moving average of $343.51 and a 200 day simple moving average of $329.40. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $7.15 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.